Author:
Felix Thomas,Patel Binakumari,Bradbury Brian D.,Grampp Gustavo
Publisher
Springer International Publishing
Reference92 articles.
1. Amgen Inc. Docket Nos. FDA-2013-P-1153; FDA-2013-P-1398, respectively, non-proprietary naming of biosimilars. 2015. Available at
http://www.regulations.gov/#!documentDetail;D=FDA-2013-P-1398-0022
. Accessed October 19, 2017.
2. AsPEN Collaborators, Andersen M, Bergman U, Choi NK, Gerhard T, Huang C, Jalbert J, Kimura M, Kimura T, Kubota K, Lai EC, Ooba N, Park BJ, Pratt N, Roughead EE, Sato T, Setoguchi S, Shin JY, Sundstrom A, Yang YH. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiol Drug Saf. 2013;22:700–4.
3. Behrman RE, Benner JS, Brown JS, McClellan M, Woodcock J, Platt R. Developing the Sentinel System--a national resource for evidence development. N Engl J Med. 2011;364:498–9.
4. Benard-Laribiere A, Miremont-Salame G, Perault-Pochat MC, Noize P, Haramburu F. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. Fundam Clin Pharmacol. 2015;29:106–11.
5. Biswas P. Pharmacovigilance in Asia. J Pharmacol Pharmacother. 2013;4:S7–S19.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献